Product image of Naloxone Polpharma (Naloxone Hydrochloride) supplied by GNH India

Naloxone Polpharma

Active Ingredient:
Naloxone Hydrochloride
Origin:
EU

Naloxone Polpharma (Naloxone Hydrochloride)

Naloxone, the active ingredient in Naloxone Polpharma, is an opioid antagonist presented as a sterile solution for intramuscular, intravenous, and subcutaneous use. It rapidly reverses opioid‑induced respiratory depression in emergency situations.
GNH India supplies Naloxone Polpharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Manufacturer / TM Owner

Zaklady Farmaceutyczne Polpharma S.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Naloxone is an opioid antagonist used in the management of opioid overdose and related emergencies.

  • Opioid overdose: rapidly reverses respiratory depression and restores consciousness.
  • Opioid toxicity: counteracts life‑threatening effects of excess opioid activity.
  • Opioid‑induced sedation: restores normal breathing and alertness.

How It Works

  • Naloxone acts as a competitive antagonist at mu‑opioid receptors, displacing opioid agonists and blocking their activation. By occupying these receptors without activating them, it reverses the central nervous system depression and respiratory compromise caused by opioids, allowing normal respiratory drive to resume.

Side Effects

Naloxone is generally well tolerated, but adverse reactions can occur.

Common Side Effects

  • Nausea
  • Vomiting
  • Sweating
  • Headache
  • Tachycardia
  • Hypertension

Serious or Rare Side Effects

  • Seizures
  • Severe hypertension or arrhythmias
  • Pulmonary edema
  • Anaphylactic reaction
  • Local injection site necrosis
  • Acute opioid withdrawal syndrome

Precautions & Warnings

Naloxone should be administered with careful clinical assessment and monitoring.

  • Airway assessment: ensure airway patency before injection.
  • Withdrawal risk: be aware of precipitated opioid withdrawal in dependent patients.
  • Cardiovascular monitoring: watch for rapid changes in blood pressure and heart rate.
  • Injection technique: avoid intravascular administration when possible.
  • Indication confirmation: use only when opioid overdose is suspected.
  • Store at ambient temperature: keep in original packaging, protect from moisture and light.

Avoid Interactions

Naloxone may interact with other medications that affect the cardiovascular or central nervous systems.

Major Interactions (Avoid)

  • Mixed agonist‑antagonist opioids (e.g., buprenorphine) may precipitate severe withdrawal.
  • High‑dose catecholamines can exacerbate hypertension after naloxone administration.
  • Beta‑blockers may mask tachycardia caused by naloxone.

Moderate Interactions (Monitor Closely)

  • Sedatives or CNS depressants may enhance residual sedation after naloxone.
  • Antihypertensive agents may require dose adjustment due to sudden blood pressure rise.
  • Tricyclic antidepressants can increase the risk of cardiac arrhythmias when combined with naloxone‑induced tachycardia.

Frequently Asked Questions

Naloxone Polpharma is used as an emergency antidote to reverse the life‑threatening effects of opioid overdose. It restores normal breathing and consciousness by blocking opioid activity at the central nervous system.

Naloxone competitively binds to mu‑opioid receptors without activating them, displacing opioid molecules and preventing further receptor stimulation. This rapid antagonism restores respiratory drive and reduces sedation caused by opioid excess.

The specific dose and route are determined by the prescribing clinician based on the severity of the overdose, patient age, weight, and clinical response. Healthcare professionals follow established protocols to titrate naloxone safely.

Safety data in pregnancy and lactation are limited, and the pregnancy category is unknown. Use is generally reserved for life‑threatening situations where the benefit outweighs potential risk, and it should be administered under medical supervision.

Submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Naloxone is the most widely used opioid antagonist due to its rapid onset and short duration, making it ideal for emergency reversal. Alternatives like nalmefene have a longer half‑life but are less commonly used in acute overdose settings.

Store the product at ambient temperature, below 25 °C, in its original packaging. Protect it from moisture, direct sunlight, and extreme temperatures to maintain potency and sterility.

Naloxone Polpharma is supplied as a sterile solution for intramuscular, intravenous, or subcutaneous injection. The route is chosen by the healthcare provider based on the clinical scenario and available access.

Serious risks include precipitated acute opioid withdrawal, severe hypertension, cardiac arrhythmias, seizures, and rare anaphylactic reactions. Immediate medical monitoring is essential after administration.

Naloxone is contraindicated in individuals with known hypersensitivity to naloxone or any component of the formulation. It should not be used when opioid overdose is not suspected, as it can induce withdrawal symptoms.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.